Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott R Drab

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Diabetes Reviews|December 24, 2015
Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and EfficacyScott R Drab
Pharmacotherapy|December 2, 2009
Diabetes mellitus. IntroductionScott R Drab
Pharmacotherapy|December 2, 2009
Clinical studies of liraglutide, a novel, once-daily human glucagon-like peptide-1 analog for improved management of type 2 diabetes mellitusScott R Drab
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|June 27, 2009
Recognizing the rising impact of diabetes in seniors and implications for its managementScott R Drab
Pharmacotherapy|May 27, 2010
Incretin-based therapies for type 2 diabetes mellitus: current status and future prospectsScott R Drab
Pharmacotherapy|October 18, 2013
A new option for glycemic control: insulin degludec, a new-generation basal insulin with an ultralong duration of actionScott R Drab, Athena Philis-Tsimikas
Pharmacotherapy|June 25, 2016
GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin RegimenMarie L Davies, David Q Pham, Scott R Drab
American Journal of Pharmaceutical Education|November 14, 2007
A Web-based interprofessional diabetes education courseDeanne L Hall, Scott R Drab, R Keith Campbell, et al.
American Journal of Pharmaceutical Education|July 1, 2009
Instructor satisfaction with a technology-based resource for diabetes educationDeanne L Hall, Shelby L Corman, Scott R Drab, et al.
The Diabetes Educator|June 7, 2008
Diabetes educators: implementing the chronic care model, Linda M Siminerio, Scott R Drab, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Diabetes Reviews|December 24, 2015
Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and EfficacyScott R Drab
Pharmacotherapy|December 2, 2009
Diabetes mellitus. IntroductionScott R Drab
Pharmacotherapy|December 2, 2009
Clinical studies of liraglutide, a novel, once-daily human glucagon-like peptide-1 analog for improved management of type 2 diabetes mellitusScott R Drab
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|June 27, 2009
Recognizing the rising impact of diabetes in seniors and implications for its managementScott R Drab
Pharmacotherapy|May 27, 2010
Incretin-based therapies for type 2 diabetes mellitus: current status and future prospectsScott R Drab
Pharmacotherapy|October 18, 2013
A new option for glycemic control: insulin degludec, a new-generation basal insulin with an ultralong duration of actionScott R Drab, Athena Philis-Tsimikas
Pharmacotherapy|June 25, 2016
GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin RegimenMarie L Davies, David Q Pham, Scott R Drab
American Journal of Pharmaceutical Education|November 14, 2007
A Web-based interprofessional diabetes education courseDeanne L Hall, Scott R Drab, R Keith Campbell, et al.
American Journal of Pharmaceutical Education|July 1, 2009
Instructor satisfaction with a technology-based resource for diabetes educationDeanne L Hall, Shelby L Corman, Scott R Drab, et al.
The Diabetes Educator|June 7, 2008
Diabetes educators: implementing the chronic care model, Linda M Siminerio, Scott R Drab, et al.
Pageof 1